Sackeim HA

Department of Psychiatry, Medical University of South Carolina, Charleston, South Carolina.

5 papers · 1 preprint · ORCID

ArticlePsilocybin

Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation: An Open-Label Trial.

van der Vaart A, LaPratt J, Swartz K +5

Europe PMC2026
ArticleKetamine

Durability of the benefit of vagus nerve stimulation in markedly treatment-resistant major depression: a RECOVER trial report.

Conway CR, Rush AJ, Aaronson ST +29

Europe PMC2026
PreprintKetamine

Durability of the Benefit of Vagus Nerve Stimulation in Markedly Treatment-Resistant Major Depression: A RECOVER Trial Report

Conway CR, Rush AJ, Aaronson ST +29

Europe PMC2025
ArticlePsilocybin

Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.

Aaronson ST, van der Vaart A, Miller T +6

Europe PMC2025
ArticlePsilocybin

Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.

Aaronson ST, van der Vaart A, Miller T +6

Europe PMC2024
ArticleKetamine

Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.

Conway CR, Aaronson ST, Sackeim HA +23

Europe PMC2024